TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 38 filers reported holding TELA BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,912 | -5.7% | 10,989 | +19.4% | 0.00% | – |
| Q2 2023 | $93,196 | +837.9% | 9,200 | +885.0% | 0.00% | – |
| Q1 2023 | $9,937 | -74.7% | 934 | -72.6% | 0.00% | – |
| Q4 2022 | $39,227 | +40.1% | 3,411 | +4.0% | 0.00% | – |
| Q3 2022 | $28,000 | +86.7% | 3,279 | +57.3% | 0.00% | – |
| Q2 2022 | $15,000 | +15.4% | 2,085 | +84.2% | 0.00% | – |
| Q1 2022 | $13,000 | -92.1% | 1,132 | -91.2% | 0.00% | – |
| Q4 2021 | $164,000 | -11.8% | 12,849 | -5.5% | 0.00% | – |
| Q3 2021 | $186,000 | -13.5% | 13,592 | +1.8% | 0.00% | – |
| Q2 2021 | $215,000 | -2.3% | 13,356 | -9.4% | 0.00% | – |
| Q1 2021 | $220,000 | +1.4% | 14,739 | +2.2% | 0.00% | – |
| Q4 2020 | $217,000 | -24.7% | 14,422 | -17.1% | 0.00% | – |
| Q3 2020 | $288,000 | +22.0% | 17,388 | -4.7% | 0.00% | – |
| Q2 2020 | $236,000 | +85.8% | 18,242 | +12.7% | 0.00% | – |
| Q1 2020 | $127,000 | -39.5% | 16,181 | 0.0% | 0.00% | – |
| Q4 2019 | $210,000 | – | 16,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
| Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
| INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
| Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
| HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
| AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
| Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
| Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
| Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |